These findings strongly suggest that although LFD is not associated with hyperlipidemia, the upregulation of CD36 by GPR40 KO increases lipid uptake and hepatic inflammation, contributing to hepatic steatosis, inflammation and fibrosis. The gene discussed is FFAR1; the disease is Hepatic steatosis.